Mike Huckman
Mike Huckman is CNBC’s Pharmaceutical Reporter covering the drug, biotechnology and medical device industries. Huckman is based at the network’s global headquarters in Englewood Cliffs, N.J.
Huckman joined CNBC in September 2000 after nine years at WXYZ-TV in Detroit where he was one of the station’s lead reporters. Prior to WXYZ-TV, he served as a general assignment reporter at KGUN-TV in Tucson, Ariz., KBCI-TV in Boise, Idaho, and as an anchor/producer for the Montana Television Network.
Huckman has won numerous awards for his reporting, including three Michigan News Emmys, one for Business and Financial reporting, as well as a first place News Series Award from the Michigan Association of Broadcasters. Huckman earned a Bachelor of Arts degree in journalism from the University of Southern California.
Mike Huckman's Latest Articles
-
Amgen CEO to Shareholders: I Feel Your Pain
on May 09, 2008 about AMGN
-
Amgen Gets a Reprieve From Activist Investor
on May 09, 2008 about AMGN
-
Merck Layoffs: Lower Drug Sales,Too Many Reps
on May 07, 2008 about MRK
-
Pfizer 'Re-Lighting' Chantix Ad Campaign For Smokers
on May 06, 2008 about PFE
- Fixing Pfizer
- Former Merck CEO Prods Industry on Drug Pricing
- Merck Tries to Adapt to Tredaptive Setback
- FDA's "Risky Business" for Pharma & Biotech
-
Amgen: Is the 'A' for Anemia or Acquisition?
on Apr 27, 2008 about AMGN
-
Pfizer CEO Doesn't Duck Tough Questions at Shareholder Meeting
on Apr 25, 2008 about PFE
- Schering Beat the Street and Plows Through Vytorin Firestorm
- Halfway Through Earnings Season, No Home Runs for Big Pharma
- Merck: Forecasting Blockbuster Sales for Gardasil
-
Has Pfizer's "Crown Jewel" Lipitor Lost Its Value?
on Apr 21, 2008 about PFE
- Starting Monday: Big Pharma Reports This Week
- GSK and Pozen "Headache Free" After Approval of Migraine Drug
-
Will Pfizer Hit a Home Run with Avant's Cancer Treatment?
on Apr 17, 2008 about PFE
- JNJ: Beat and Boosted Earnings, But Still Waiting for FDA's Procrit Ruling
-
Dendreon's Secret "Lover" Revealed: It's Not Icahn
on Apr 16, 2008 about DNDN
-
GE: Are Hospital Equipment Makers in the ER?
on Apr 15, 2008 about GE
-
Genentech Earnings: Great Formatting, But Not So Great Sales
on Apr 13, 2008 about DNA
- MannKind: No Partnership Likely for Inhalable Insulin
- Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts?
- Russian Roulette Pays Off for Antigenics
- Schering-Plough: The Vytorin-Zetia Backstory
- Levitra's New Ad: Focusing on Medical Issues
-
Dendreon's Secret Investor
on Apr 04, 2008 about DNDN
-
A "Bone Of Contention" with Amgen's Bone Drug Data?
on Apr 04, 2008 about AMGN
-
Pfizer's Failures and Fight for Lipitor
on Apr 03, 2008 about PFE
- Vytorin Battle Pits Merck and SGP against Pfizer
- ACC Not With Merck and SGP on Vytorin/Zetia
- Drug Companies "Banking" on Dems This Election
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Trading Center
- About Seeking Alpha
- About Us
- , Contact
- What's New
- Readers Feedback
- Tools & Widgets
- Stock Market Toolbar
- Stock Search Add-on
- Power Search
- Email Alerts
- Live Feeds (RSS)
- Legal
- Terms of Use
- Privacy
- Copyright
- Advertise
Want to talk to our community?
Got something interesting to say?
- Advertise with Us
Latest Commentson Mike Huckman's Articles